Back to search
Histiocytosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Histiocytosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Histiocytosis trials you may qualify forThis phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that…
This open-label study aims to gather long-term safety, tolerability, PK, biomarker, and clinical efficacy data relating to daily administration of Nizubaglustat…
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late…
An 18-month double-blind, randomized, placebo-controlled, multicenter, Phase 3 study to evaluate the safety and efficacy of oral nizubaglustat (AZ-3102) in late…
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
This is a phase 1b clinical trial to assess the efficacy of rapcabtagene autoleucel (YTB323) administered at the recommended dose in adults with Large B Cell Ly…
Phase 1 study comprised of open-label, dose escalation and expansion cohort study of P-CD19CD20-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in subjec…